Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
lidocainhydrochlorid 1 % injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 % injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely lidocaine hydrochloride 30 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 100 mg/ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 12 mg/dosis, spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 1,5 % injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,5 % injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 40 mg/ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 4 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidokainhydrochlorid 4 % + fluoresceinnatrium 0,25 % øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid + chlorhexidin 1 %/0,25 % gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid + chlorhexidin 2 %/0,25 % gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
adrenalinbitartrat 5 µg + lidocainhydrochlorid 10 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Epinephrine bitartrate + lidocaine hydrochloride 10mcg/20mg inj |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Epinephrine bitartrate + lidocaine hydrochloride 20mcg/20mg inj |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Chlorhexidine gluconate+lidocaine hydrochloride 0.2%/0.05% throat spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
chlorhexidingluconat 0,2 % + lidocainhydrochlorid 0,05 % halsspray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Domiphen bromide 500 microgram and lidocaine hydrochloride 5 mg oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Domiphen bromide+lidocaine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocain 0,5 mg, pulver til injektionsvæske til intrakutan anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 40 mg/mL oropharyngeal solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 % halsspray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
methylprednisolonacetat 80 mg/2 ml+ lidocainhydrochlorid 20 mg/2 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
methylprednisolonacetat 40/1 ml + lidocainhydrochlorid 10 mg/1 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 35 mg/g eye gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,5 % injektionsvæske, opløsning, 20 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 %/adrenalin 1:200.000 injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,5 % injektionsvæske, opløsning, 10 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
adrenalin 5 µg + lidocainhydrochlorid 15 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,2 % + glucose 5 %, Polyfusor-flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 1 % injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,5 % injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 % injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,4 % + glucose 5 % i Polyfusor-flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
adrenalin 10 µg + lidocainhydrochlorid 10 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
adrenalin 20 µg + lidocainhydrochlorid 20 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
adrenalin 10 µg + lidocainhydrochlorid 20 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 1 %/adrenalin 1:200.000 injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid + glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 1,5 %/adrenalin 1:200.000 injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 %/adrenalin 1:500.000 injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 1 % injektionsvæske, opløsning, 2 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,5 % injektionsvæske, opløsning, 20 ml hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 1 % injektionsvæske, opløsning, 10 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 1 % injektionsvæske, opløsning, 20 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 1 % injektionsvæske, opløsning, 5 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 %/adrenalin 1:100.000 injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid + adrenalin 4 % næsedråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 % injektionsvæske, opløsning, 20 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 % injektionsvæske, opløsning, 5 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 % injektionsvæske, opløsning, 2 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 % injektionsvæske, opløsning, 20 ml hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
dexamethasonnatriumphosphat + lidocainhydrochlorid 4 mg/10 mg/ml injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 1 %/adrenalin 1:100.000 injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 5 %/glucose 7,5 % injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,4 %/glucose 5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,2 %/glucose 5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,6 % + glucose 5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,1 %/glucose 5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocainhydrochlorid, tung 5 % steril injektionsvæske, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 4 % injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
lidocainhydrochlorid 2 % steril injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
dextrose 7,5 % wt/wt/lidocainhydrochlorid 1,5 % wt/wt injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride+epinephrine 4% conventional release nasal drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride+fluorescein sodium 4%/0.25% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Chlorhexidine gluconate+lidocaine hydrochloride 0.2%/0.05% conventional release oromucosal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 20 mg/mL oromucosal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 5% injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Domiphen bromide 500 microgram and lidocaine hydrochloride 5 mg oromucosal lozenge |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Domiphen bromide 500 microgram and lidocaine hydrochloride 5 mg oromucosal lozenge |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 5 mg/g cutaneous gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 5 mg/g cutaneous gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 10 mg/mL cutaneous gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 10 mg/mL cutaneous gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 50 milligram/1 gram conventional release gingival ointment (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 50 milligram/1 gram conventional release gingival ointment (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely cetylpyridinium chloride 1 milligram/1 gram and lidocaine hydrochloride 3.3 milligram/1 gram conventional release dental gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely cetylpyridinium chloride 1 milligram/1 gram and lidocaine hydrochloride 3.3 milligram/1 gram conventional release dental gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
lidocain + phenylephrin 5 %/0,5 % spray til topikal anvendelse, opløsning |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
lidocain + phenylephrin 5 %/0,5 % spray til topikal anvendelse, opløsning |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Hydrocortisone 2 mg/g and lidocaine hydrochloride 10 mg/g cutaneous spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Hydrocortisone 2 mg/g and lidocaine hydrochloride 10 mg/g cutaneous spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 100 milligram/5 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 100 milligram/5 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 400 milligram/20 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 400 milligram/20 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 400 milligram/20 milliliter conventional release solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 400 milligram/20 milliliter conventional release solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 50 milligram/5 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 50 milligram/5 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 40 milligram/2 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 40 milligram/2 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 50 milligram/10 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 50 milligram/10 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 200 milligram/20 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 200 milligram/20 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |